CRISPR/Cas9-mediated disruption of USO1 significantly altered cell growth and the cell cycle in B-ALL cell lines; as well as inhibited the colony forming potential of MLL-transformed primary murine bone marrow cells. Here, USO1 is linked to acute lymphoblastic leukemia.